Tofogliflozin decreases body fat mass and improves peripheral insulin resistance

The impact of tofogliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on peripheral glucose uptake in patients with type 2 diabetes mellitus (T2DM) was investigated using the hyperinsulinaemic‐euglycaemic clamp method in a single‐arm, open‐label study. The following variables were compared betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuba, Ren, Matsuba, Ikuro, Shimokawa, Mototsugu, Nagai, Yoshio, Tanaka, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2018
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947308/
https://www.ncbi.nlm.nih.gov/pubmed/29316197
http://dx.doi.org/10.1111/dom.13211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947308/
https://www.ncbi.nlm.nih.gov/pubmed/29316197
http://dx.doi.org/10.1111/dom.13211

Ejemplares similares